Observed Glycemic and Psychosocial Benefits in the Prospective Bigfoot Unity Real World Study: A 6-Month Analysis
In this study primarily of older adults with T2D using MDI, durable glycemic improvement occurred using the System at 6 months, with the frequency of hypoglycemia being substantially below established targets of < 4% and < 1% for time below 70 and 54 mg/dL, respectively.
Authors
- Rakesh Nandan (ORCID: https://orcid.org/0000-0001-6023-9003)
- Fazal Sheikh (ORCID: https://orcid.org/0000-0002-2640-851X)
- Thomas J. Mouse
- John B. Tillman (ORCID: https://orcid.org/0000-0003-2912-2370)
- Peter M. Calhoun (ORCID: https://orcid.org/0000-0002-5325-7200)
- Roy W. Beck (ORCID: https://orcid.org/0000-0002-5194-8446)
- Jeanne L. Jacoby (ORCID: https://orcid.org/0000-0003-0003-3753)
- William H. Polonsky (ORCID: https://orcid.org/0000-0001-9064-6144)
- Ryan J. Bailey (ORCID: https://orcid.org/0000-0001-5763-4598)
- James Malone
Institutions
- Fluor (United States) (US)
- Abbott (United States) (US)
- Sansum Diabetes Research Institute (US)
- Diabetes Care Center (US)
- Institute of Behavioral Sciences (JP)
- Jaeb Center for Health Research (US)
- Abbott Diabetes Care (United States)
- Intuit (United States) (US)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2024-11-15
- DOI
- https://doi.org/10.1210/clinem/dgae778
- Citations
- 1
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.36
Funders
- Abbott Laboratories
- Abbott Diabetes Care